$PTOS
P2 Solar, Inc.

2024 Q3 Form 10-K Financial Statement

#000164033424001124 Filed on July 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2024
Revenue $7.353K $12.05K $166.3K
YoY Change -92.04%
Cost Of Revenue $4.167K $7.930K $99.31K
YoY Change -91.64%
Gross Profit $3.186K $4.120K $66.98K
YoY Change -92.51%
Gross Profit Margin 43.33% 34.19% 40.28%
Selling, General & Admin $23.85K $181.9K
YoY Change
% of Gross Profit 578.88% 271.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $38.03K $23.84K $181.9K
YoY Change -35.98% 105.59%
Operating Profit -$34.84K -$19.72K -$114.9K
YoY Change 106.64% 29.9%
Interest Expense -$26.76K $32.91K
YoY Change 2.09%
% of Operating Profit
Other Income/Expense, Net $2.873K $0.00 -$33.49K
YoY Change -62.39%
Pretax Income -$46.47K -$148.4K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$31.97K -$46.47K -$148.4K
YoY Change -22.86% -16.39%
Net Earnings / Revenue -434.76% -385.64% -89.26%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 67.95M shares 67.95M shares
Diluted Shares Outstanding 67.95M shares

Balance Sheet

Concept 2024 Q3 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $210.00 $210.00
YoY Change -97.25%
Cash & Equivalents $235.00 $213.00
Short-Term Investments
Other Short-Term Assets $3.900K $3.900K
YoY Change
Inventory
Prepaid Expenses $3.914K $3.900K
Receivables $50.00 $11.86K $11.86K
Other Receivables $8.390K $8.390K
Total Short-Term Assets $12.80K $24.36K $24.36K
YoY Change -78.22% 44.07% 44.06%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $90.25K $90.25K
YoY Change 2748.93% 2748.93%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $90.25K $90.25K $90.25K
YoY Change 2748.93% 2749.83% 2756.01%
TOTAL ASSETS
Total Short-Term Assets $12.80K $24.36K $24.36K
Total Long-Term Assets $90.25K $90.25K $90.25K
Total Assets $103.0K $114.6K $114.6K
YoY Change 66.45% 470.95% 471.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $270.0K $270.0K
YoY Change 22.76%
Accrued Expenses $293.6K $293.6K
YoY Change 11.02%
Deferred Revenue
YoY Change
Short-Term Debt $1.297M $1.297M
YoY Change 6.04%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.935M $1.860M $1.860M
YoY Change 6.46% 8.97% 8.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $87.09K $87.09K
YoY Change
Total Long-Term Liabilities $87.09K $87.09K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.935M $1.860M $1.860M
Total Long-Term Liabilities $87.09K $87.09K
Total Liabilities $2.011M $1.947M $1.947M
YoY Change 10.66% 14.07% 14.07%
SHAREHOLDERS EQUITY
Retained Earnings -$8.178M -$8.110M
YoY Change 1.85% 1.86%
Common Stock $67.95K $67.95K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.908M -$1.833M -$1.833M
YoY Change
Total Liabilities & Shareholders Equity $103.0K $114.6K $114.6K
YoY Change 66.45% 470.95% 471.05%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$31.97K -$46.47K -$148.4K
YoY Change -22.86% -16.39%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$9.710K -$27.67K
YoY Change -49.58%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.670K $19.73K
YoY Change -12.83%
NET CHANGE
Cash From Operating Activities -9.710K -$27.67K
Cash From Investing Activities
Cash From Financing Activities -1.670K $19.73K
Net Change In Cash -11.38K -$7.431K
YoY Change 1215.22%
FREE CASH FLOW
Cash From Operating Activities -$9.710K -$27.67K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001172069
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67946513 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
333-91190
CY2024 dei Entity Registrant Name
EntityRegistrantName
P2 SOLAR, INC.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0234680
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
13718 91 Avenue
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Surrey
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
British Columbia
CY2024 dei Entity Address Country
EntityAddressCountry
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V3V 7X1
CY2024 dei City Area Code
CityAreaCode
778
CY2024 dei Local Phone Number
LocalPhoneNumber
321-0047
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
false
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
244550 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67946513 shares
CY2024 dei Auditor Firm
AuditorFirmId
2807
CY2024 dei Auditor Name
AuditorName
Bansal & Co. LLP,
CY2024 dei Auditor Location
AuditorLocation
New Delhi, India
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-148426 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-177528 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-148426 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-177528 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1639129 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
129580 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-177528 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1687077 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2812 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-148426 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1832691 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-148426 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-177528 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11910 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2024 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
865 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-141 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3918 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3589 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
50582 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12185 usd
CY2024 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
29614 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
50407 usd
CY2024 ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
55521 usd
CY2023 ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
56600 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27672 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54888 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
67381 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16629 usd
CY2024 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
56549 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18995 usd
CY2024 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
54127 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2024 ptos Proceeds From Issuance Of Promissory Notes
ProceedsFromIssuanceOfPromissoryNotes
0 usd
CY2023 ptos Proceeds From Issuance Of Promissory Notes
ProceedsFromIssuanceOfPromissoryNotes
25000 usd
CY2024 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
63025 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19730 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22634 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
511 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31690 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7431 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-564 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8208 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
3799 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024 ptos Non Cash Transaction Goodwill Generated From Acquisition Of Subsidiary
NonCashTransactionGoodwillGeneratedFromAcquisitionOfSubsidiary
0 usd
CY2023 ptos Non Cash Transaction Goodwill Generated From Acquisition Of Subsidiary
NonCashTransactionGoodwillGeneratedFromAcquisitionOfSubsidiary
90254 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
8390 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9263 usd
CY2024Q1 us-gaap Goodwill
Goodwill
90254 usd
CY2024 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
36331 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
83170 usd
CY2024 ptos Convertible Notes Issued To Non Affiliates
ConvertibleNotesIssuedToNonAffiliates
62731 usd
CY2024 us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.05 pure
CY2024 us-gaap Interest Expense
InterestExpense
32911 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-148426 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-177528 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.26 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.26 pure
CY2024 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
38591 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
46157 usd
CY2024 ptos Valuation Allowance Change In Amount
ValuationAllowanceChangeInAmount
38591 usd
CY2023 ptos Valuation Allowance Change In Amount
ValuationAllowanceChangeInAmount
46157 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2108675 usd
CY2023Q1 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2070084 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9263 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
16907 usd
CY2023Q1 us-gaap Goodwill
Goodwill
90254 usd
CY2023Q1 us-gaap Assets
Assets
107161 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
219896 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
264482 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
526339 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
18473 usd
CY2023Q1 ptos Due To Related Party Current
DueToRelatedPartyCurrent
677962 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1707152 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
87086 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1794238 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
67947 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6542783 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7961863 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-335944 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1687077 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
107161 usd

Files In Submission

Name View Source Status
0001640334-24-001124-index-headers.html Edgar Link pending
0001640334-24-001124-index.html Edgar Link pending
0001640334-24-001124.txt Edgar Link pending
0001640334-24-001124-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ptos-20240331.xsd Edgar Link pending
ptos_10k.htm Edgar Link pending
ptos_10kimg2.jpg Edgar Link pending
ptos_10kimg3.jpg Edgar Link pending
ptos_10kimg4.jpg Edgar Link pending
ptos_ex101.htm Edgar Link pending
ptos_ex101img11.jpg Edgar Link pending
ptos_ex101img6.jpg Edgar Link pending
ptos_ex101img7.jpg Edgar Link pending
ptos_ex101img8.jpg Edgar Link pending
ptos_ex101img9.jpg Edgar Link pending
ptos_ex311.htm Edgar Link pending
ptos_ex312.htm Edgar Link pending
ptos_ex321.htm Edgar Link pending
ptos_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
ptos_10k_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ptos-20240331_cal.xml Edgar Link unprocessable
ptos-20240331_pre.xml Edgar Link unprocessable
ptos-20240331_def.xml Edgar Link unprocessable
ptos-20240331_lab.xml Edgar Link unprocessable